Beta-Cell Mass in Obesity and Type 2 Diabetes, and Its Relation to Pancreas Fat: A Mini-Review

Overview

Journal Nutrients

Date 2020 Dec 19

PMID 33339276

Citations 39

Authors

Jun Inaishi

Yoshifumi Saisho

Affiliations

Soon will be listed here.

Abstract

Type 2 diabetes (T2DM) is characterized by insulin resistance and beta-cell dysfunction. Although insulin resistance is assumed to be a main pathophysiological feature of the development of T2DM, recent studies have revealed that a deficit of functional beta-cell mass is an essential factor for the pathophysiology of T2DM. Pancreatic fat contents increase with obesity and are suggested to cause beta-cell dysfunction. Since the beta-cell dysfunction induced by obesity or progressive decline with disease duration results in a worsening glycemic control, and treatment failure, preserving beta-cell mass is an important treatment strategy for T2DM. In this mini-review, we summarize the current knowledge on beta-cell mass, beta-cell function, and pancreas fat in obesity and T2DM, and we discuss treatment strategies for T2DM in relation to beta-cell preservation.

Citing Articles

The Importance of Edible Medicinal Mushrooms and Their Potential Use as Therapeutic Agents Against Insulin Resistance.

Nemeth Z, Paulinne Bukovics M, Sumegi L, Sturm G, Takacs I, Simon-Szabo L Int J Mol Sci. 2025; 26(2).

PMID: 39859540 PMC: 11765957. DOI: 10.3390/ijms26020827.

Evolving Characteristics of Type 2 Diabetes Mellitus in East Asia.

Lee J, Yoon K Endocrinol Metab (Seoul). 2025; 40(1):57-63.

PMID: 39814030 PMC: 11898318. DOI: 10.3803/EnM.2024.2193.

L11 and LR: Ameliorate Obesity via AMPK Pathway.

Liang S, Sun J, Gu X, Zhao Y, Wang X, Tao H Nutrients. 2025; 17(1.

PMID: 39796438 PMC: 11723306. DOI: 10.3390/nu17010004.

Increased circulating serpinB1 levels in children with overweight/obesity are associated with obesity-related parameters: a cross‑sectional study.

Li Q, Li Z, Guo S, Li S, Yao M, Li Y BMC Pediatr. 2024; 24(1):762.

PMID: 39578813 PMC: 11585230. DOI: 10.1186/s12887-024-05251-7.

Associations of HIV and prevalent type 2 diabetes mellitus in the context of obesity in South Africa.

Magodoro I, Castle A, Tshuma N, Goedecke J, Sewpaul R, Manasa J J Multimorb Comorb. 2024; 14:26335565241293691.

PMID: 39492946 PMC: 11528680. DOI: 10.1177/26335565241293691.

References

Xu X, DHoker J, Stange G, Bonne S, De Leu N, Xiao X . Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell. 2008; 132(2):197-207. DOI: 10.1016/j.cell.2007.12.015. View

Weyer C, Bogardus C, Mott D, Pratley R . The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest. 1999; 104(6):787-94. PMC: 408438. DOI: 10.1172/JCI7231. View

Utzschneider K, Prigeon R, Faulenbach M, Tong J, Carr D, Boyko E . Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care. 2008; 32(2):335-41. PMC: 2628704. DOI: 10.2337/dc08-1478. View

Taylor R . Type 2 diabetes: etiology and reversibility. Diabetes Care. 2013; 36(4):1047-55. PMC: 3609491. DOI: 10.2337/dc12-1805. View

Lee Y, Lingvay I, Szczepaniak L, Ravazzola M, Orci L, Unger R . Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents. Int J Obes (Lond). 2009; 34(2):396-400. DOI: 10.1038/ijo.2009.245. View

Saisho Y . Pancreas Volume and Fat Deposition in Diabetes and Normal Physiology: Consideration of the Interplay Between Endocrine and Exocrine Pancreas. Rev Diabet Stud. 2016; 13(2-3):132-147. PMC: 5553763. DOI: 10.1900/RDS.2016.13.132. View

Butler A, Dhawan S, Hoang J, Cory M, Zeng K, Fritsch H . β-Cell Deficit in Obese Type 2 Diabetes, a Minor Role of β-Cell Dedifferentiation and Degranulation. J Clin Endocrinol Metab. 2015; 101(2):523-32. PMC: 4880126. DOI: 10.1210/jc.2015-3566. View

Del Prato S, Camisasca R, Wilson C, Fleck P . Durability of the efficacy and safety of alogliptin compared with glipizide in type 2 diabetes mellitus: a 2-year study. Diabetes Obes Metab. 2014; 16(12):1239-46. DOI: 10.1111/dom.12377. View

Atkinson M, Eisenbarth G, Michels A . Type 1 diabetes. Lancet. 2013; 383(9911):69-82. PMC: 4380133. DOI: 10.1016/S0140-6736(13)60591-7. View

10.

Steven S, Hollingsworth K, Small P, Woodcock S, Pucci A, Aribisala B . Weight Loss Decreases Excess Pancreatic Triacylglycerol Specifically in Type 2 Diabetes. Diabetes Care. 2015; 39(1):158-65. DOI: 10.2337/dc15-0750. View

11.

Philippe M, Benabadji S, Barbot-Trystram L, Vadrot D, Boitard C, Larger E . Pancreatic volume and endocrine and exocrine functions in patients with diabetes. Pancreas. 2011; 40(3):359-63. DOI: 10.1097/MPA.0b013e3182072032. View

12.

Meier J, Menge B, Breuer T, Muller C, Tannapfel A, Uhl W . Functional assessment of pancreatic beta-cell area in humans. Diabetes. 2009; 58(7):1595-603. PMC: 2699865. DOI: 10.2337/db08-1611. View

13.

Lee Y, Hirose H, Ohneda M, Johnson J, McGarry J, Unger R . Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci U S A. 1994; 91(23):10878-82. PMC: 45129. DOI: 10.1073/pnas.91.23.10878. View

14.

Inada A, Nienaber C, Katsuta H, Fujitani Y, Levine J, Morita R . Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth. Proc Natl Acad Sci U S A. 2008; 105(50):19915-9. PMC: 2604974. DOI: 10.1073/pnas.0805803105. View

15.

Pal A, McCarthy M . The genetics of type 2 diabetes and its clinical relevance. Clin Genet. 2012; 83(4):297-306. DOI: 10.1111/cge.12055. View

16.

Roden M, Price T, Perseghin G, Petersen K, Rothman D, Cline G . Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest. 1996; 97(12):2859-65. PMC: 507380. DOI: 10.1172/JCI118742. View

17.

Mezza T, Muscogiuri G, Sorice G, Clemente G, Hu J, Pontecorvi A . Insulin resistance alters islet morphology in nondiabetic humans. Diabetes. 2013; 63(3):994-1007. PMC: 3931397. DOI: 10.2337/db13-1013. View

18.

Sato S, Saisho Y, Inaishi J, Kou K, Murakami R, Yamada T . Effects of Glucocorticoid Treatment on β- and α-Cell Mass in Japanese Adults With and Without Diabetes. Diabetes. 2015; 64(8):2915-27. DOI: 10.2337/db15-0151. View

19.

Laedtke T, Kjems L, Porksen N, Schmitz O, Veldhuis J, Kao P . Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes. Am J Physiol Endocrinol Metab. 2000; 279(3):E520-8. DOI: 10.1152/ajpendo.2000.279.3.E520. View

20.

Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S . Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia. 2002; 45(1):85-96. DOI: 10.1007/s125-002-8248-z. View